Research on covid-19 is suffering “imperfect incentives at every stage”
- 28 May 2020
- Vol. 369, m2045
- https://doi.org/10.1136/bmj.m2045
Abstract
The rush to publish and report during the pandemic is compromising quality, worried experts tell Stephen ArmstrongKeywords
This publication has 5 references indexed in Scilit:
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area (vol 323, pg 2050, 2020)Jama-Journal Of The American Medical Association, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJama-Journal Of The American Medical Association, 2020
- Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With HypertensionPublished by Cold Spring Harbor Laboratory ,2020
- An international comparison of the second derivative of COVID-19 deaths after implementation of social distancing measuresPublished by Cold Spring Harbor Laboratory ,2020
- Relationship between the ABO Blood Group and the COVID-19 SusceptibilityPublished by Cold Spring Harbor Laboratory ,2020